US Medicare Agency Reconsidering Proposed Accelerated Approval Payment Demo

 
• By Laura Helbling

The US Medicare agency is not moving forward with a proposal to cut payments for drugs with accelerated approval status pending further discussions with the FDA about whether new regulatory authorities have addressed concerns about timely completion of confirmatory trials.

health care payment
The CMMI accelerated approval payment demo is not on hold, but undergoing further discussions. • Source: Shutterstock

More from Pricing Debate

More from Market Access